baber/WOPTO huggingface dataset:
Patent CA-3059463-A1 (CA)
Title: Plastic bag making apparatus
Inventor: TOTANI MIKIO
IPC: B26D7/18
Filed: 2018-04-05
Abstract: An apparatus is provided for disposing of waste from making plastic bags from plastic film. Waste is formed in at least two areas adjacent to each other widthwise of the plastic film. The apparatus includes a suction path, a partition plate, an optical sensor and a controller. The partition plate defines the suction path widthwise of the plastic film into at least two divided paths. The partition plate is disposed in the suction paths. The waste is guided to each of the divided paths and discharged. The optical sensor detects the waste discharged from each of the paths.  The controller performs an action such as an alarm when the waste are not discharged to each of the divided paths. The controller is connected with the optical sensor. The partition plate is moved in a widthwise direction relative to the plastic film.
Patent CA-3060241-A1 (CA)
Title: Validation using key pairs and interprocess communications
Inventor: MANDAARA NISHANTH
IPC: H04W12/06
Filed: 2019-10-25
Abstract: A validation system that includes a server and a validation terminal. The server is configured to receive location information for a mobile device and to determine the mobile device is at a registered location. The server is further configured to process a transaction for the products in a digital cart, to generate a barcode, and to encrypt the barcode using a private key linked with the registered location. The server is further configured to send the encrypted barcode to the mobile device. The validation engine is configured to scan the encrypted barcode using a barcode reader and to decrypt the encrypted barcode using the stored public key that is linked with the private key. The validation terminal is further configured to indicate the transaction is valid in response to decrypting the encrypted barcode using the public key.
Patent CA-3062280-A1 (CA)
Title: Automated drying and curing chamber
Inventor: KOZLOWSKI DAN
IPC: A24B3/04
Filed: 2018-05-01
Abstract: Machines, systems and methods for curing materials, including organic and nonorganic materials, are described. In particular, machines, systems and methods for machines, systems and methods for materials, such as organic plant materials or inorganic materials, including cannabis materials. In particular, the present invention relates to machines, systems and methods for an automated drying and curing chamber machine for both personal and commercial applications, wherein the machine uses customized variable settings and laminar air flow dynamics via negative pressure to ensure the optimal curing and drying environment for plant materials are described.
Patent CA-3063310-A1 (CA)
Title: System, device and method for providing passenger or user information
Inventor: O'SULLIVAN KEVIN
IPC: H04W12/08
Filed: 2018-05-18
Abstract: A computer processing device (119, 121, 123, 131, 133, 135) for determining whether to allow or deny access to a database associated with the device is provided. The device is configured to determine the origin of data signed with a first key (125) by comparing the key to one or more keys stored in the or a further database to identify the source of the data; search the database to determine one or more access rules associated with the source of the data, wherein the access rules define whether write access to the database is allowed or denied for the data; and allow or deny write access to the database based on the determined rule or rules.
Patent CA-3063464-A1 (CA)
Title: High activity regulatory elements
Inventor: RAMAMOORTHI KARTIK
IPC: C12N15/85
Filed: 2018-05-18
Abstract: Provided herein are compositions and methods for driving high expression of a transgene. Compositions and methods for driving high expression of a transgene comprising one or more human-derived regulatory elements, which, when operably linked to a transgene, can result in high expression of the transgene in one or more cell types or tissues.
Patent CA-3066321-A1 (CA)
Inventor: SOBREIRA CORREIA ILIDIO JOAQUIM
IPC: A61K9/06
Filed: 2018-07-17
Abstract: La présente demande de brevet concerne une pellicule mise au point à partir de composants d'origine naturelle pour revêtir des plaies, son procédé d'application étant réalisé sous la forme d'emballages individuels jetables, d'ampoules, de seringues et/ou analogues. Cette pellicule assure un environnement humide à la plaie, de sorte que puisse se produire le débridement autolytique naturel. La pellicule comprend des agents bioactifs tels que, par exemple, de l'acide acétylsalicylique, des huiles essentielles, des extraits de plantes et analogues, qui confèrent des propriétés antibactériennes, antifongiques, anti-inflammatoires, antioxydantes et régénératrices. Le procédé d'application permet en outre de simplifier la vie des patients et de réduire au minimum la douleur et la gêne qu'ils ressentent, lors du traitement effectué dans le cadre des premiers soins.
Patent CA-3069571-A1 (CA)
Inventor: HAYAKAWA TOMOHISA
IPC: C12N5/074
Filed: 2018-08-07
Abstract: An immortalized sweat gland myoepithelial cell which expresses .alpha.-SMA  and pan-cytokeratin and has a sphere forming ability after subculture at least times. A method for producing immortalized sweat gland myoepithelial cells, said method comprising: while culturing a cell structure, wherein sweat gland myoepithelial cells are exposed on a surface, in a state of being suspended in a medium, transferring an immortalizing gene into the cells; and then culturing the transgenic structure thus obtained in a state of being suspended in the medium to thereby obtain immortalized sweat gland myoepithelial cells.
Patent CA-3070491-A1 (CA)
Title: Pumping system shaft conversion adapter
Inventor: ASHURST JOSEPH
IPC: F04D13/10
Filed: 2018-07-20
Abstract: A pump for use in a motorized pumping system has a pump shaft with a lower ring groove and an upper ring groove. The pump also includes a lower adapter and an upper adapter. The lower adapter has a pair of lower ring halves configured to fit within the lower ring groove and the upper adapter has a pair of upper ring halves configured to fit within the upper ring groove. The pump further includes a plurality of stages that each have a stationary diffuser and a rotating impeller. The rotating impellers are connected to the shaft with a keyed connection that permits the impeller to axially travel along the shaft. Also disclosed is a method for converting a compression shaft to a floater shaft that includes the steps of placing an upper adapter into the upper ring groove, placing one or more impellers on the shaft, placing one or more standard spacers on the shaft and placing a lower adapter into the lower ring groove.
Patent CA-3073944-A1 (CA)
Title: Formules de sincalide stables au stockage
Inventor: SUNDARAM SRIKANTH
IPC: A61K38/08
Filed: 2018-08-24
Abstract: La présente invention concerne des compositions solides qui comprennent du sincalide et sont stables au stockage et qui sont dépourvues de tampon, et facultativement, sont également dépourvues d'agent tensioactif/agent de solubilisation, de telles compositions étant stables au stockage. L'invention concerne également des compositions liquides qui comprennent du sincalide, de telles compositions étant stables au stockage, et pouvant être dépourvues de tampon et/ou de tensioactif/solubilisant. L'invention concerne également des procédés de fabrication et d'administration des compositions stables au stockage solides ou liquides à un patient les nécessitant, par exemple, dans le traitement, la prévention et/ou le diagnostic de troubles de la vésicule biliaire et/ou du pancréas; ou d'autres imageries de diagnostic.
Patent CA-3076439-A1 (CA)
Title: Device and method for distinguishing a test gas escaping from a leak from interfering gas
Inventor: WETZIG DANIEL
IPC: G01M3/22
Filed: 2018-09-28
Abstract: The invention relates to a method for distinguishing a test gas escaping from a leak in a test object (21) from an interfering gas in the environment of the test object (21) during sniffing leak detection, comprising the following steps: suctioning gas from the environment of the test object (21) in the region of the outer surface of the test object by means of a sniffing tip, which has a suction opening (14), which is connected, for gas conduction, to a sensor (18), which is designed to determine the test gas partial pressure of the test gas in the suctioned gas flow; varying, with periodic repetition, the flow intensity of the suctioned gas flow; setting a total pressure of the suctioned gas at the sensor (18) of at least 80 percent of the total pressure of the gas in the atmosphere (23) surrounding the test object (21); avoiding fluctuations of the total pressure of the suctioned gas at the sensor (18) of more than 10 percent; measuring the test gas partial pressure of test gas contained in the suctioned gas flow by means of the sensor (18); indicating that the test object (21) has a leak if the measured test gas partial pressure has a varying component, the average amplitude of which lies above a threshold value and which follows the variation of the suctioned gas flow.
Patent CA-3080453-A1 (CA)
Inventor: HAKSPIEL STEFAN
IPC: G01S7/481
Filed: 2020-05-07
Abstract: The present invention relates to a semiconductor package and to a LIDAR  transmitting unit comprising such a semiconductor package. The semiconductor package comprises a surface-emitting laser, at least one driver circuit for the surface-emitting laser, a connecting structure and at least one interposer.  The connecting structure comprises a plurality of solder bumps. The surface-emitting laser is electrically connected to the at least one driver circuit via the at least one interposer and the connecting structure.
Patent CA-3081798-A1 (CA)
Title: A double-labeled probe for molecular imaging and use thereof
Inventor: EDER ANN-CHRISTIN
IPC: A61K49/00
Filed: 2018-11-12
Abstract: The present invention relates to a compound or a pharmaceutically acceptable salt thereof having a chemical structure comprising:  A compound or a pharmaceutically acceptable salt thereof of formula (I):  (A)-x1-(B)-x2-(C), wherein (A) is at least one motif specifically binding to cell membranes of neoplastic cells; (B) at least one chelator moiety of radiometals; (C) a dye moiety; x1 is a spacer covalently connecting (A) and (B); x2 is a spacer or a chemical single bond connecting (B) and (C); wherein (C) has the formula wherein R1 to R4, R9, a, b, Y and X1 to X4 have the meaning as indicated in the claims and description The invention further relates to compositions comprising said compounds as well as a method for detecting neoplastic cells in a sample in vitro with the aid of the compounds or composition
Patent CA-3081963-A1 (CA)
Inventor: TAN BARRIE
IPC: A61K31/352
Filed: 2020-05-29
Abstract: The present embodiments are directed to compositions comprising quillaja extract and at least one active ingredient such as nutritional supplement, dietary ingredient, medicine, and food additive, and methods for preparations and use thereof.
Patent CA-3084909-A1 (CA)
Title: A nasal device
Inventor: KANWAR SANJIV
IPC: A61M15/08
Filed: 2018-12-05
Abstract: The present invention provides a nasal breathing control apparatus (10) having one or more axially extending cylinders (12) having a first end (14), a second end (16), a mid-portion (18) and an inner chamber (20) having a first inner end (20a) and a second inner end (20b) and extending along a longitudinal axis (X) together with a first opening (22) in said first end (14) connected to said inner chamber (20), a second opening (24) in said second end (16), connected to said inner chamber (20) and a float (26) having a first end (26a) and a second end (26b) within the inner chamber (20) and being movable between a first position FP in which it obturates said first opening (22) and a second position SP in which it partially obturates the second opening (24); wherein each of the one or more axially extending cylinders (12) is tapered and wherein the cross-section of each of the one or more cylinders (12) comprises a width (W) that decreases from said first end (14) towards said second end (16) of the cylinder. Such a device may be used to assist a patient in improving the quality and volume that they can speak by controlling the breathing pattern or method of the patient.
Patent CA-3085006-A1 (CA)
Title: Processes for making modulators of cystic fibrosis transmembrane conductance regulator
Inventor: ANGELL PAUL T
IPC: C07D401/14
Filed: 2018-12-07
Abstract: The disclosure provides processes for preparing a compound of Formula (I).
Patent CA-3088691-A1 (CA)
Inventor: GUNTHER WILLIAM R
IPC: C10M101/02
Filed: 2019-02-18
Abstract: La présente invention concerne des adsorbants pour adsorption aromatique qui sont utilisés pour améliorer une ou plusieurs propriétés d'huiles de base dérivées de fractions d'huile désasphaltée. Les adsorbants peuvent permettre l'élimination de produits aromatiques polynucléaires à partir d'un effluent intermédiaire ou d'un effluent final pendant la production d'huile de base. L'élimination de produits aromatiques polynucléaires peut être bénéfique pour améliorer la couleur d'huiles de base neutres lourdes et/ou réduire la turbidité d'huiles brillantes.
Patent CA-3088717-A1 (CA)
Inventor: RIED THOMAS
IPC: B01D53/04
Filed: 2019-01-10
Abstract: The invention relates to a method for separating a gas mixture flow, in which use is made of a temperature-change adsorption plant (100) which has a number of adsorption units (A1, A2, A3) which are respectively operated in a first operating mode and a second operating mode, wherein the first operating mode comprises guiding the gas mixture flow (G) at least in part through an adsorption chamber of the respective adsorption unit (A1, A2, A3) and subjecting this flow to an adsorptive exchange of material with at least one adsorbent in its adsorption chamber, and the second operating mode comprises guiding a first heat transfer fluid flow (W1) at a first temperature through a heat-exchange arrangement of the respective adsorption unit (A1, A2, A3) and transferring heat from the first heat transfer fluid flow (W1) indirectly to the at least one adsorbent in its adsorption chamber. It is provided that the first operating mode comprises guiding a second heat transfer fluid flow (W2) at a second temperature through the heat-exchange arrangement of the respective adsorption unit (A1, A2, A3) and transferring heat from the at least one adsorbent in its adsorption chamber indirectly to the second heat transfer fluid flow (W2), and the adsorption units (A1, A2, A3) are respectively operated in a third operating mode which comprises guiding a third heat transfer fluid flow (W3) at a third temperature through the heat-exchange arrangement of the respective adsorption unit (A1, A2, A3) and transferring heat from the at least one adsorbent in its adsorption chamber to the third heat transfer fluid flow (W3). The invention also relates to a corresponding temperature-change adsorption plant (100).
Patent CA-3090414-A1 (CA)
Inventor: WU LEI
IPC: A61P35/00
Filed: 2019-02-22
Abstract: La présente invention concerne des composés bifonctionnels comprenant une fraction (par exemple, le lénalidomide, le thalidomide) qui est un liant d'une ubiquitine ligase E3 (par exemple, la protéine cereblon) et une autre fraction (par exemple, le RA190) qui est un liant du récepteur RPN13 de l'ubiquitine pour induire une dégradation du RPN13 et ainsi inhiber la fonction du protéasome.<i /> <i /> <i /> L'invention concerne également des compositions pharmaceutiques comprenant les composés bifonctionnels, et des méthodes de traitement et/ou de prévention de maladies (par exemple, des maladies prolifératives, des cancers, des néoplasmes bénins, une angiogenèse pathologique, des maladies inflammatoires et des maladies auto-immunes).<i /> L'invention concerne également des méthodes d'induction de la dégradation du récepteur RPN13 de l'ubiquitine par l'administration d'un composé bifonctionnel ou d'une composition décrits dans la description, un constituant du composé bifonctionnel étant un liant d'une ubiquitine ligase E3 (par exemple, le lénalidomide, le thalidomide) et un autre constituant du composé étant un liant du récepteur RPN13 de l'ubiquitine (par exemple, le RA190), chez un sujet.<i /> <i />
Patent CA-3090762-A1 (CA)
Title: Insoles, insoles for high heel shoes, and methods of making and using same
Inventor: BUCK CHRISTOPHER
IPC: A43B13/14
Filed: 2019-02-06
Abstract: An insole for a shoe can include a top surface, an opposing bottom surface, a rear end and an opposing front end. At least a section of the top surface proximate the rear end can be concave. At least a section of the bottom surface proximate the rear end can be convex. A plurality of spaced-apart holes can extend through the insole from the top surface to the bottom surface. The plurality of spaced-apart holes can be arranged in two rows. A first row of the two rows can be spaced radially inward with respect to a second row of the two rows. Each of the plurality of holes of the first row can have the same size. Each of the plurality of holes of the second row can have the same size.
Patent CA-3092880-A1 (CA)
Inventor: BOURQUE STEVEN MICHAEL
IPC: B26B21/44
Filed: 2019-03-27
Abstract: A handle (12) for a shaving razor in which the handle comprises a frame and a movable member assembly operably coupled to the frame such that the frame is disposed between the movable member assembly and where the movable member assembly portions are configured to move both above and below the frame. The movement can be linear or rotational. The movable member assembly comprises one or more springs. A razor handle includes a rigid member (18), a first member (19) having one or more movable elements wherein a portion of the first member is connected to a first surface of the rigid member, a second member, the second member (20) coupled to a second surface of the rigid member wherein a benefit delivery assembly is disposed in an area between the rigid member and the second member.
Patent CA-3095019-A1 (CA)
Inventor: LABELLE MARC
IPC: A61K31/44
Filed: 2013-10-01
Abstract: 87210600 ABRÉGÉ Il est décrit des composés pouvant moduler lactivité dhistones déméthylases (HDME), y compris la H3C00 0 CH3 1 H I NN NN,Ci.i3 ,..,,_, ,..-.113 ou un sel pharmaceutiquement acceptable de celle-ci. Les composés peuvent servir à prévenir et/ou à traiter des maladies ayant une composante de dérégulation génomique, comme le cancer. La présente demande concerne également des compositions pharmaceutiques comprenant lesdits composés et lutilisation de tels composés comme médicament. Date reçue/Date Received 2020-10-01
Patent CA-3097805-A1 (CA)
Title: Shipping box
Inventor: LOPEZ MASAGUE MANUEL
IPC: B65D5/54
Filed: 2019-04-26
Abstract: The invention relates to a shipping box made up of a sheet, said box comprising: a lid (10), which comprises two inner flaps (2) and at least one outer flap (3), said at least one outer flap (3) comprising at least a sealing element (5) and at least a tear strip (4), a base (11), and four side walls (12, 13) in which the length (L1) of the at least one outer flap (3) is greater than the length (L2) of the inner flaps (2), defining a projecting portion (30) on the at least one outer flap (3) which projects with respect to the inner flaps (2) in the unfolded position of the sheet that forms the box, such that said at least one sealing element (5) and said at least one tear strip (4) are arranged on said projecting portion (30).
Patent CA-3098983-A1 (CA)
Inventor: NAM DO-HYUN
IPC: C07K16/28
Filed: 2019-05-02
Abstract: La présente invention concerne un anticorps anti-c-Met qui est réactif de manière croisée vis-à-vis de c-Met humain et de souris, et une utilisation de celui-ci et, plus particulièrement : un anticorps anti-c-Met ou un fragment de liaison à l'antigène de celui-ci ; un anticorps bispécifique ou un conjugué anticorps-médicament comprenant l'anticorps ou le fragment de liaison à l'antigène de celui-ci ; une composition pharmaceutique pour prévenir ou traiter le cancer les comprenant ; un acide nucléique codant pour l'anticorps ou le fragment de liaison à l'antigène de celui-ci ; un vecteur et une cellule hôte comprenant l'acide nucléique ; un procédé de préparation d'un anticorps anti-c-Met ou d'un fragment de liaison à l'antigène de celui-ci à l'aide dudit procédé ; et une composition de traitement du cancer co-administré contenant l'anticorps anti-c-Met ou un fragment de liaison à l'antigène de celui-ci et un autre agent de traitement du cancer. L'anticorps se liant à c-Met et le fragment de liaison à l'antigène de celui-ci, selon la présente invention, peuvent se lier à c-Met humain et murin avec une affinité élevée, ce qui permet d'identifier des résultats précliniques plus précis dans une évaluation d'efficacité en utilisant des modèles de tumeur de souris. L'anticorps se liant à c-Met et le fragment de liaison à l'antigène de celui-ci, selon la présente invention, peuvent être utilisés de manière efficace pour prévenir ou traiter un cancer cible.
Patent CA-3100005-A1 (CA)
Title: Activatable cytokine polypeptides and methods of use thereof
Inventor: WINSTON WILLIAM
IPC: C07K19/00
Filed: 2019-05-14
Abstract: The disclosure features fusion proteins that are conditionally active variants of a cytokine of interest. In one aspect, the full-length polypeptides of the invention have reduced or minimal cytokine-receptor activating activity even though they contain a functional cytokine polypeptide. Upon activation, e.g., by cleavage of a linker that joins a blocking moiety, e.g. a steric blocking polypeptide, in sequence to the active cytokine, the cytokine can bind its receptor and effect signaling. Typically, the fusion proteins further comprise an in vivo half-life extension element, which may be cleaved from the cytokine in the tumor microenvironment.
Patent CA-3100035-A1 (CA)
Inventor: PASSNO CHRISTINA
IPC: C07K16/00
Filed: 2019-08-26
Abstract: L'invention concerne des procédés et des systèmes de spectroscopie Raman in situ permettant de caractériser ou de quantifier un intermédiaire de purification de protéine et/ou un pool de concentré final pendant la production ou la fabrication. Dans un mode de réalisation, la spectroscopie Raman in situ est utilisée pour caractériser ou quantifier des attributs de qualité critique d'intermédiaires de purification de protéines pendant un traitement en aval (c'est-à-dire après la récolte de l'intermédiaire de purification de protéines). Par exemple, les procédés et systèmes de spectroscopie Raman in situ selon l'invention peuvent être utilisés pour caractériser et quantifier des intermédiaires de purification de protéines à mesure que les intermédiaires de purification de protéines sont purifiés, condensés, ou autrement formulés dans le produit médicamenteux final à vendre ou à administrer.
Patent CA-3100124-A1 (CA)
Title: In-wall ladder for swimming pool
Inventor: NELSON LAURENCE A
IPC: E06C9/02
Filed: 2020-11-19
Abstract: ABSTRACT An in-wall ladder to be installed in a swimming pool, and a method of constructing the ladder, the ladder including a frame portion configured with a substantially flat front surface and a central opening, a plurality of step portions configured to extend back from the front surface of the frame portion, in a substantially parallel arrangement in the central opening, and a plurality of riser portions configured to extend back in the central opening at an angle from the front surface of the frame portion to a point proximate a back edge of each respective step portion located below each respective riser portion. Attorney Docket No. 83344.00 Date Recue/Date Received 2020-11-19